New kid on the block in theranostics: Glypican-3 Luca FilippiOrazio Schillaci Spotlight 23 January 2021 Pages: 199 - 201
Applying thyroid cancer guidelines: a difficult task Savvas FrangosEvanthia GiannoulaIoannis Iakovou Spotlight 19 April 2021 Pages: 203 - 207
PET findings after COVID-19 vaccination: “Keep Calm and Carry On” Giorgio TregliaMarco CuzzocreaLuigia Elzi Spotlight 13 May 2021 Pages: 209 - 214
Androgen deprivation therapy and its modulation of PSMA expression in prostate cancer: mini review and case series of patients studied with sequential [68Ga]-Ga-PSMA-11 PET/CT Riccardo MeiSergio BracardaPaolo Castellucci Mini-Review 23 March 2021 Pages: 215 - 220
Breast cancer: initial workup and staging with FDG PET/CT David GroheuxElif Hindie Expert Review 27 April 2021 Pages: 221 - 231
Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review Luca GiovanellaRosaria M. RuggeriDesiree Deandreis Systematic Review 11 March 2021 Pages: 233 - 240
Magnetic resonance imaging in mood disorders: a bibliometric analysis from 1999 to 2020 Mingzhou GaoHui SunMingqi Qiao Systematic Review Open access 06 May 2021 Pages: 241 - 254
Impact of 18F-FDG PET on the management of recurrent breast cancer: a meta-analysis Kyoungjune PakHai-Jeon YoonHyun Yul Kim Meta-Analysis 15 April 2021 Pages: 255 - 263
Assessment of therapy response to Regorafenib by 18F-DOPA-PET/CT in patients with recurrent high-grade gliomas: a case series Eugenio Di GiorgioAlberto CuocoloMarco Spadafora Pictorial Essay 06 March 2021 Pages: 265 - 274
Somatostatin receptor imaging and therapy in differentiated thyroid cancer: a ray of hope or the flash before total darkness? Emran AskariAtena AghaeiKamran Aryana Letter to the Editor 05 April 2021 Pages: 275 - 276